ARCHIVES

SWOG Closes Prostate Cancer Trial With Mitoxantrone

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

September 4, 1998

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979